Search research articles
Contact Us
Filters
Showing results (591-600 of 835) with videos related to
Page
of 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2011
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers
Charles Coutant, Roman Rouzier, Yuan Qi, et al.
Revue Neurologique
|
July 23, 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma
M Fontanilles, A Deniel, F Marguet, et al.
Plos One
|
January 20, 2023
Executive functioning in adolescents and adults with Silver-Russell syndrome
Mélissa Burgevin, Agnès Lacroix, Fanny Ollivier, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
March 12, 2023
Evaluation of catch-up growth in severe pediatric Hashimoto's hypothyroidism
A Vincent, C Bouvattier, C Teinturier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2019
Closed-loop cycles of experiment design, execution, and learning accelerate systems biology model development in yeast
Anthony Coutant, Katherine Roper, Daniel Trejo-Banos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 2021
Lower Circulating Sertoli and Leydig Cell Hormone Levels During Puberty in Obese Boys: A Cross-sectional Study
Solene Rerat, Jessica Amsellem-Jager, Marie Clemence L'hour, et al.
NPJ Breast Cancer
|
February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2014
HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
Olivier Humbert, Alexandre Cochet, Jean-Marc Riedinger, et al.
Frontiers in Oncology
|
January 26, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, et al.
Genes & Diseases
|
February 7, 2025
Assessment of the transcriptomic consequences and MAU2 protein levels in edited induced pluripotent stem cells with <i>NIPBL</i> pathogenic variants
Kévin Cassinari, Anne Rovelet-Lecrux, Céline Derambure, et al.
Page
of 84
Search research articles
Search
Showing results (591-600 of 835) with videos related to
Sort By:
Page
of 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2011
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers
Charles Coutant, Roman Rouzier, Yuan Qi, et al.
Revue Neurologique
|
July 23, 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma
M Fontanilles, A Deniel, F Marguet, et al.
Plos One
|
January 20, 2023
Executive functioning in adolescents and adults with Silver-Russell syndrome
Mélissa Burgevin, Agnès Lacroix, Fanny Ollivier, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
March 12, 2023
Evaluation of catch-up growth in severe pediatric Hashimoto's hypothyroidism
A Vincent, C Bouvattier, C Teinturier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 18, 2019
Closed-loop cycles of experiment design, execution, and learning accelerate systems biology model development in yeast
Anthony Coutant, Katherine Roper, Daniel Trejo-Banos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 2021
Lower Circulating Sertoli and Leydig Cell Hormone Levels During Puberty in Obese Boys: A Cross-sectional Study
Solene Rerat, Jessica Amsellem-Jager, Marie Clemence L'hour, et al.
NPJ Breast Cancer
|
February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2014
HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
Olivier Humbert, Alexandre Cochet, Jean-Marc Riedinger, et al.
Frontiers in Oncology
|
January 26, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, et al.
Genes & Diseases
|
February 7, 2025
Assessment of the transcriptomic consequences and MAU2 protein levels in edited induced pluripotent stem cells with <i>NIPBL</i> pathogenic variants
Kévin Cassinari, Anne Rovelet-Lecrux, Céline Derambure, et al.
Page
of 84